Amgen: all 1,085 studies

Page 5 of 11. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.

• Darbepoetin Alfa in Patients With Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)CompletedNCT01362140Phase 3Results posted
• Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs)CompletedNCT01347073Phase 3Results posted
• Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple MyelomaCompletedNCT01345019Phase 3Results posted
• Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)CompletedNCT01327612Phase 2Results posted
• Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque PsoriasisCompletedNCT01313221Phase 3Results posted
• Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)CompletedNCT01313208Phase 4Results posted
• Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)CompletedNCT01307423Phase 3Results posted
• A Study of Carfilzomib vs Best Supportive Care in Subjects With Relapsed and Refractory Multiple MyelomaCompletedNCT01302392Phase 3Results posted
• Effects of Denosumab on the Pharmacokinetics of EtanerceptTerminatedNCT01294397Phase 1Results posted
• Study to Evaluate Cinacalcet in Children With Chronic Kidney DiseaseCompletedNCT01290029Phase 1Results posted
• Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid ArthritisTerminatedNCT01285310Phase 2Results posted
• Pediatric Chronic Kidney Disease Safety and EfficacyTerminatedNCT01277510Phase 3Results posted
• Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) PatientsCompletedNCT01270347Phase 3Results posted
• To Evaluate the Safety of Long-term Use of HPN-100 in the Management of Urea Cycle Disorders (UCDs)CompletedNCT01257737Phase 4Results posted
• Evaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT01235442Phase 3Results posted
• Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.CompletedNCT01232283Phase 3Results posted
• The Effects of Denosumab on the Pharmacokinetics (PK) of MidazolamCompletedNCT01221727Phase 1Results posted
• PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic ArthritisCompletedNCT01212770Phase 3Results posted
• PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic ArthritisCompletedNCT01212757Phase 3Results posted
• Study of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)CompletedNCT01209286Phase 2Results posted
• Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)CompletedNCT01207388Phase 2Results posted
• Long-term Safety Study of Brodalumab in Adults With Crohn's DiseaseTerminatedNCT01199302Phase 2Results posted
• A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled AsthmaCompletedNCT01199289Phase 2Results posted
• Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)CompletedNCT01197378Phase 3Results posted
• Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT01194219Phase 3Results posted
• Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing HemodialysisCompletedNCT01181531Phase 4Results posted
• MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic FibrosisCompletedNCT01180634Phase 3Results posted
• Efficacy and Safety Study of Apremilast to Treat Active Psoriatic ArthritisCompletedNCT01172938Phase 3Results posted
• Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck CancerTerminatedNCT01161498Phase 3Results posted
• Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's DiseaseTerminatedNCT01150890Phase 2Results posted
• Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving RomiplostimCompletedNCT01143038Phase 2Results posted
• Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Evolocumab (AMG 145) in Adults With Hyperlipidemia on Stable Doses of a StatinCompletedNCT01133522Phase 1Results posted
• A Single-dose Study Evaluating Romosozumab (AMG 785) in Healthy Postmenopausal Japanese and Non-Japanese WomenCompletedNCT01101061Phase 1Results posted
• Study To Assess FRacTure Healing With SclerosTin Antibody - HipCompletedNCT01081678Phase 2Results posted
• Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple MyelomaCompletedNCT01080391Phase 3Results posted
• Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)TerminatedNCT01077154Phase 3Results posted
• A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia PurpuraCompletedNCT01071954Phase 3Results posted
• Safety and Efficacy of AMG 827 in Subjects With RATerminatedNCT01059448Phase 2Results posted
• A First-in-human Study Evaluating Romosozumab (AMG 785) in Healthy Men and Postmenopausal WomenCompletedNCT01059435Phase 1Results posted
• ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal CancerCompletedNCT01001377Phase 3Results posted
• The Efficacy and Safety of Adding Methotrexate to Etanercept in PsoriasisCompletedNCT01001208Phase 3Results posted
• Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With CystinosisCompletedNCT01000961Phase 3Results posted
• A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic EncephalopathyCompletedNCT00999167Phase 2Results posted
• Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle DisordersCompletedNCT00992459Phase 3Results posted
• Darbepoetin Alfa and Anemia of CancerTerminatedNCT00989092Phase 2Results posted
• Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug TreatmentCompletedNCT00984815Phase 3Results posted
• Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With OsteoporosisCompletedNCT00980174Phase 3Results posted
• Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo ParathyroidectomyCompletedNCT00975221Phase 3Results posted
• Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant RecipientsCompletedNCT00975000Phase 3Results posted
• Safety Study of Tezepelumab (AMG 157) in Healthy AdultsCompletedNCT00972179Phase 1Results posted
• Brodalumab (AMG 827) in Rheumatoid Arthritis (RA) Participants With Inadequate Response to MethotrexateCompletedNCT00950989Phase 2Results posted
• A Study to Evaluate the Effect of Romosozumab (AMG 785) on Bone Quality of the Forearm in Postmenopausal Women With Low Bone MassCompletedNCT00950950Phase 1Results posted
• Open Label Extension to SRE Studies in United Kingdom and Czech Republic OnlyCompletedNCT00950911Phase 3Results posted
• Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle DisordersCompletedNCT00947544Phase 2Results posted
• Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)CompletedNCT00947297Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly BisphosphonatesCompletedNCT00936897Phase 3Results posted
• PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical PracticeCompletedNCT00928408Results posted
• Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone LossCompletedNCT00925600Phase 3Results posted
• Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney DiseaseCompletedNCT00925587Phase 3Results posted
• Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate TherapyCompletedNCT00919711Phase 3Results posted
• PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation StudyCompletedNCT00911170Phase 3Results posted
• Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP)CompletedNCT00907478Phase 4Results posted
• Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary NailingCompletedNCT00907296Phase 2Results posted
• Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral DensityCompletedNCT00896532Phase 2Results posted
• Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum CalciumCompletedNCT00896454Phase 2Results posted
• A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With DenosumabCompletedNCT00890981Phase 3Results posted
• A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With DenosumabCompletedNCT00887965Phase 2Results posted
• A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment ProtocolsCompletedNCT00884312Phase 2Results posted
• A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic ChemotherapyCompletedNCT00883181Results posted
• Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With CystinosisCompletedNCT00872729Phase 1/2Results posted
• A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet DiseaseCompletedNCT00866359Phase 2Results posted
• Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving ChemotherapyTerminatedNCT00858364Phase 3Results posted
• AMG 386 Phase 2 Open-Label Renal Cell Carcinoma (RCC) Study 1st Line or After Cytokine Failure in Combination With SunitinibCompletedNCT00853372Phase 2Results posted
• Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate CancerCompletedNCT00838201Phase 3Results posted
• European Union Registry in Paediatric Chronic Kidney Disease Patients Looking at Safety and Usage Patterns of Darbepoetin AlfaCompletedNCT00838097Results posted
• PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) TumorsCompletedNCT00819780Phase 2Results posted
• 20070360 Incident DialysisCompletedNCT00803712Phase 4Results posted
• Moderate to Severe Plaque Psoriasis With Scalp InvolvementCompletedNCT00791765Phase 4Results posted
• Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)CompletedNCT00773734Phase 2Results posted
• Study to Evaluate the Safety, PK, PD and Efficacy of AMG 827 in Adults With Rheumatoid ArthritisCompletedNCT00771030Phase 1/2Results posted
• Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in MelanomaCompletedNCT00769704Phase 3Results posted
• Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic DermatitisCompletedNCT00757042Phase 1Results posted
• A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckCompletedNCT00756444Phase 2Results posted
• A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00739648Phase 2Results posted
• LEARN-6™: A Prospective, Observational Nursing Home StudyCompletedNCT00727571Results posted
• Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal FunctionCompletedNCT00721734Phase 2Results posted
• A New Modified-release Tablet Formulation of Prednisone (Lodotra®) in Patients With Nocturnal AsthmaCompletedNCT00686335Phase 2Results posted
• Study of Denosumab in Subjects With Giant Cell Tumor of BoneCompletedNCT00680992Phase 2Results posted
• Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) PatientsCompletedNCT00677365Phase 2Results posted
• Phase IIa Study of Fomepizole for Acetaldehyde Toxicity After Ethanol Exposure in Subjects With Altered Ethanol MetabolismCompletedNCT00661141Phase 2Results posted
• Panitumumab in Children With Solid TumorsCompletedNCT00658658Phase 1Results posted
• CAMEO: Canadian Methotrexate and Etanercept Outcome StudyCompletedNCT00654368Phase 4Results posted
• Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid ArthritisCompletedNCT00650078Phase 3Results posted
• Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer StudyCompletedNCT00630786Phase 1/2Results posted
• Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)CompletedNCT00614523Phase 2Results posted
• Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary EndpointTerminatedNCT00613730Phase 2Results posted
• Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg) in Subjects Who Have Completed Participation in HZ-CA-301 (NCT00450658) or HZ-CA-303 (NCT00450216)CompletedNCT00613106Phase 3Results posted
• P3 Study to Evaluate Efficacy and Safety of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic PurpuraCompletedNCT00603642Phase 3Results posted
• Phase 1b Multicenter Study of Carfilzomib With Lenalidomide and Dexamethasone in Relapsed Multiple MyelomaCompletedNCT00603447Phase 1Results posted
• Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic EncephalopathyTerminatedNCT00597909Phase 2Results posted

← Amgen overview and focus areas